BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7899367)

  • 1. [Chemotherapy of small cell bronchial cancers. Prognostic importance of complete response (1,280 patients). Groupe Petites Cellules].
    Lebeau B; Chastang C; Schuller MP; Thiberville L; Vaylet F; Derenne JP; Caillaud D; Muir JF; Coëtmeur D; Lemarié E
    Presse Med; 1995 Jan; 24(4):217-21. PubMed ID: 7899367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.
    Pujol JL; Parrat E; Lehmann M; Gautier V; Daurès JP; Michel FB; Godard P
    Am J Respir Crit Care Med; 1996 Jan; 153(1):243-9. PubMed ID: 8542123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pretherapeutic prognostic factors in small cell bronchial cancer].
    Niederle N; Eberhardt W; Hirche H
    Onkologie; 1988; 11 Suppl 2():34-40. PubMed ID: 2851760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
    Paesmans M; Sculier JP; Lecomte J; Thiriaux J; Libert P; Sergysels R; Bureau G; Dabouis G; Van Cutsem O; Mommen P; Ninane V; Klastersky J
    Cancer; 2000 Aug; 89(3):523-33. PubMed ID: 10931451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raised serum urea predicts for early death in small cell lung cancer.
    Winter MC; Potter VA; Woll PJ
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):745-50. PubMed ID: 18845424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial. The "Petites Cellules" Group.
    Lebeau B; Chastang C; Allard P; Migueres J; Boita F; Fichet D
    Eur Respir J; 1992 Mar; 5(3):286-90. PubMed ID: 1315294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
    Takifuji N; Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Masuda N; Ryu S; Sakai N; Kubota K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):429-34. PubMed ID: 2157364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
    Yamamoto N; Tamura T; Fukuoka M; Saijo N
    Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of chemo-radiotherapy and prognostic factors of small cell lung cancer.
    Shikaura S; Kawa S; Yoshida M; Yonezu S
    Radiat Med; 1991; 9(2):70-6. PubMed ID: 1658856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
    Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos HP; Kosmidis P; Skarlos DV
    Anticancer Res; 2002; 22(6B):3749-57. PubMed ID: 12552988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of prognostic factors of survival in patients with unresectable non-small cell lung cancer].
    Muraki M; Toda Y; Haraguchi R; Sugihara R; Kubo H; Nakajima S
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):585-92. PubMed ID: 1849389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
    Lebeau B; Urban T; Bréchot JM; Paillotin D; Vincent J; Leclerc P; Meekel P; L'Her P; Lebas FX; Chastang C
    Cancer; 1999 Oct; 86(8):1480-7. PubMed ID: 10526276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practice.
    Brueckl WM; Herbst L; Lechler A; Fuchs F; Schoeberl A; Zirlik S; Klein P; Brunner TB; Papadopoulos T; Hohenberger W; Hahn EG; Wiest GH
    Anticancer Res; 2006; 26(6C):4825-32. PubMed ID: 17214347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.